Has the licensing of respiratory quinolones for adults and the 7-valent pneumococcal conjugate vaccine (PCV-7) for children had herd effects with respect to antimicrobial non-susceptibility in invasive Streptococcus pneumoniae?

被引:19
作者
Fenoll, A. [2 ]
Aguilar, L. [1 ]
Granizo, J. J. [3 ]
Gimenez, M. J. [1 ]
Aragoneses-Fenoll, L. [2 ]
Mendez, C. [4 ]
Tarrago, D. [2 ]
机构
[1] Univ Complutense, Sch Med, Dept Microbiol, E-28040 Madrid, Spain
[2] Inst Salud Carlos III, Spanish Natl Reference Pneumococcal Lab, Madrid 28220, Spain
[3] Grana Datos SL, Madrid 28223, Spain
[4] Wyeth Farma SA, Dept Med, Madrid 28700, Spain
关键词
D O I
10.1093/jac/dkn413
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
The aim of the study was to analyse the evolution of antibiotic non-susceptibility in Spanish invasive Streptococcus pneumoniae after licensure of respiratory-quinolones for adults and 7-valent pneumococcal conjugate vaccine (PCV-7) for immunization of children. All invasive pneumococci received in the Reference Laboratory (January 2000-August 2007; n = 12 957 isolates) were serotyped, and susceptibility to penicillin/erythromycin/levofloxacin was determined. Antibiotic consumption and PCV-7 doses/year were provided by IMS and the manufacturer, respectively. In 2000-07, PCV-7 distribution (doses/1000 inhabitants <= 59 months age/year) increased from 0.0 to 411.90, and antibiotic consumption (DDD/1000 inhabitants/day) was maintained for beta-lactams (approximate to 16), decreased for macrolides (from 4.4 to 2.7) and increased for respiratory fluoroquinolones (from 0.3 to 2.7). The increase in PCV-7 distribution correlated with a decrease in PCV-7 serotypes prevalence among invasive isolates in children (r = -0.976; P < 0.001) and adults (r = -0.905; P = 0.002). This decrease in PCV-7 serotypes correlated with a decrease in penicillin non-susceptibility in children (r = 0.929; P < 0.001) and adults (r = 0.905; P = 0.002) and with erythromycin non-susceptibility in children (r = 0.833; P = 0.010). Penicillin/erythromycin non-susceptibility in 2000 was significantly higher in paediatric versus adult isolates (penicillin: 51.4% versus 29.2%; erythromycin: 39.5% versus 20.4%), but similar in 2006-07 (20% to 24%). The increase in respiratory quinolones consumption correlated with the increase in levofloxacin non-susceptibility in adults (r = 0.926; P = 0.008) but not in children, with different non-susceptibility rates in 2007 (1.6% versus 0.0%; P = 0.013). This ecological analysis suggests that PCV-7 vaccination in children had a herd effect in adults, but consumption of respiratory quinolones in adults had no effect on pneumococcal susceptibility to levofloxacin in children. Penicillin/erythromycin non-susceptibility decreased along the studied period among paediatric invasive S. pneumoniae isolates to a level similar to that seen in adults.
引用
收藏
页码:1430 / 1433
页数:4
相关论文
共 18 条
  • [1] [Anonymous], 1999, WKLY EPIDEMIOL REC
  • [2] Reduction in pediatric invasive pneumococcal disease in the Basque Country and Navarre, Spain, after introduction of the heptavalent pneumococcal conjugate vaccine
    Aristegui, J.
    Bernaola, E.
    Pocheville, I.
    Garcia, C.
    Arranz, L.
    Duran, G.
    Perez, L.
    Bastida, M.
    Canduela, C.
    Aguirre, M. Herranz
    Garrote, E.
    Fletcher, M. A.
    Perez, C.
    [J]. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2007, 26 (05) : 303 - 310
  • [3] Effectiveness of the 7-valent pneumococcal conjugate vaccine: A population-based case-control study
    Barricarte, Aurelio
    Castilla, Jesus
    Gil-Setas, Alberto
    Torroba, Luis
    Navarro-Alonso, Jose Antonio
    Irisarri, Fatima
    Arriazu, Maite
    [J]. CLINICAL INFECTIOUS DISEASES, 2007, 44 (11) : 1436 - 1441
  • [4] Postlicensure surveillance for pneumococcal invasive disease after use of heptavalent pneumococcal conjugate vaccine in Northern California Kaiser Permanente
    Black, S
    Shinefield, H
    Baxter, R
    Austrian, R
    Bracken, L
    Hansen, J
    Lewis, E
    Fireman, B
    [J]. PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2004, 23 (06) : 485 - 489
  • [5] Invasive pneumococcal disease among children in a health district of Barcelona:: early impact of pneumococcal conjugate vaccine
    Calbo, E.
    Diaz, A.
    Canadell, E.
    Fabrega, J.
    Uriz, S.
    Xercavins, M.
    Morera, M. A.
    Cuchi, E.
    Rodriguez-Carballeira, M.
    Garau, J.
    [J]. CLINICAL MICROBIOLOGY AND INFECTION, 2006, 12 (09) : 867 - 872
  • [6] Clinical and Laboratory Standards Institute, 2008, M100S18 CLSI
  • [7] Clinical and Laboratory Standards Institute, 2006, M7A7 CLSI
  • [8] Dot blot assay for the serotyping of pneumococci
    Fenoll, A
    Jado, I
    Vicioso, D
    Casal, J
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 1997, 35 (03) : 764 - 766
  • [9] Antimicrobial susceptibility and pneumococcal serotypes
    Fenoll, A
    Asensio, G
    Jado, I
    Berrón, S
    Camacho, MT
    Ortega, M
    Casal, J
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2002, 50 : 13 - 19
  • [10] FENOLL A, 1991, REV INFECT DIS, V13, P56